In November 2018 at the Medical Innovation Summit, the Cleveland Clinic recently announced its annual list of the top 10 medical innovations for 2019, OH. The advances are expected to enhance health care and were selected by a panel of Cleveland Clinic physicians and scientists. The list included regular features like AI, 3-D Printing, AR/VR etc. However, there were some distinct medical innovations also that it listed. Let’s have a look at some of them.
Pharmacogenomic testing can tailor prescribed medical treatments based on individual drug metabolism by determining patients’ genetic makeup. For example, it can determine how patients will respond to opioid therapy, potentially decreasing opioid abuse.
With some experts optimistic about the technology and others pessimistic, outside clinical consensus on the benefits of pharmacogenomic testing is split. Despite technological advances in the field and greater access to genetic testing, clinicians have been slow to implement pharmacogenomics. The US and European stakeholders are examining the clinical utility of pharmacogenomics and the establishment of appropriate guidelines.
The FDA cleared the Cerebrotech Visor in 2018, a noninvasive spectroscopy device that measures changes in the distribution of cerebral fluids. It couples these findings with machine-learning to enhance algorithms and detect certain brain pathologies, such as stroke, trauma, and swelling. This technology can help detect hemorrhagic stroke, which accounts for 40% of stroke deaths despite being less common than ischemic stroke.
RNA therapeutics stymie RNA genetic abnormalities before these abnormalities are translated into functioning or nonfunctioning proteins. Antisense nucleotides and RNA interference are some of the examples of this technology and are applicable to rare genetic diseases, cancer, and neurologic illness.